BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
July 12, 2006
View Archived Issues
Intercell's €110M Funding Provides Exit Opportunity
Intercell AG rounded off the largest fund raising in Europe this year, with the placing of an overallotment of 1.3 million shares, bringing the total to €110.6 million (US$140.9 million). (BioWorld International)
Read More
Genmab's Humax-CD20 Starts Phase III Work With NHL Focus
Read More
Breast Cancer Gene Might Mean Help For More Women
Read More
Novozymes Getting Protein Production, More From Delta
Read More
Early Funding Source To Be Provided By IP Group
Read More
Eurofins Scientific Invests In Danish, Japanese Food Firms
Read More
LTKfarma Setting Up Shop With Product In Phase I/II
Read More
Paradigm's Fourth Round: £7M For Cancer Drug Trials
Read More
Other News To Note
Read More